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Abstract
The Fragile X-Related 1 gene (FXR1) is a paralog of the Fragile X Mental Retardation 1 gene (FMR1), whose absence causes
the Fragile X syndrome, the most common form of inherited intellectual disability. FXR1P plays an important role in normal
muscle development, and its absence causes muscular abnormalities in mice, frog, and zebrafish. Seven alternatively spliced
FXR1 transcripts have been identified and two of them are skeletal muscle-specific. A reduction of these isoforms is found in
myoblasts from Facio-Scapulo Humeral Dystrophy (FSHD) patients. FXR1P is an RNA–binding protein involved in
translational control; however, so far, no mRNA target of FXR1P has been linked to the drastic muscular phenotypes caused
by its absence. In this study, gene expression profiling of C2C12 myoblasts reveals that transcripts involved in cell cycle and
muscular development pathways are modulated by Fxr1-depletion. We observed an increase of p21—a regulator of cell-
cycle progression—in Fxr1-knocked-down mouse C2C12 and FSHD human myoblasts. Rescue of this molecular phenotype
is possible by re-expressing human FXR1P in Fxr1-depleted C2C12 cells. FXR1P muscle-specific isoforms bind p21 mRNA via
direct interaction with a conserved G-quadruplex located in its 39 untranslated region. The FXR1P/G-quadruplex complex
reduces the half-life of p21 mRNA. In the absence of FXR1P, the upregulation of p21 mRNA determines the elevated level of
its protein product that affects cell-cycle progression inducing a premature cell-cycle exit and generating a pool of cells
blocked at G0. Our study describes a novel role of FXR1P that has crucial implications for the understanding of its role
during myogenesis and muscle development, since we show here that in its absence a reduced number of myoblasts will be
available for muscle formation/regeneration, shedding new light into the pathophysiology of FSHD.
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Introduction
The Fragile X-Related 1 (FXR1) gene belongs to a small gene
family that includes the Fragile X Mental Retardation 1 (FMR1)
and Fragile X-Related 2 (FXR2) genes (reviewed in [1]). Human
FMR1 is located on chromosome Xq27.3 [2] and inactivation of
FMR1 expression leads to the Fragile X syndrome in human, the
first cause of inherited mental retardation [5]. FXR1 and FXR2 are
autosomal genes, respectively mapping at 3q28 and 17p13.1 [3,4].
The FXR1 gene is highly expressed in muscle and its pre-mRNA is
known to undergo extensive alternative splicing, which generates
distinct FXR1 mRNA variants that produce FXR1P isoforms with
divergent C-terminal regions [6,7]. Four isoforms ranging from 70
to 80 KDa (Isoa, Isob, Isoc, Isod) are ubiquitously expressed,
including in murine [7,8] and human myoblasts [9]. Myoblasts
also express long muscle-specific FXR1 mRNA variants, termed
Isoe and Isof, which are massively induced upon muscular
differentiation [7,8,9,10]. Importantly, these muscle-specific
mRNA variants of FXR1 are the only expressed in adult muscle
[6,7,8,9,11]. Defects in FXR1 gene muscular pattern of expression
have been observed in patients affected by Facio-Scapulo Humeral
Distrophy (FSHD), the most prevalent muscular dystrophy
affecting adults and children [9]. Similar defects were observed
in a mouse model of myotonic dystrophy (DM1, [12]). As a result,
the long isoforms FXR1P Isoe and Isof of 82–84 kDa are depleted
in myopathic muscle. Consistent with these altered expression
pattern of FXR1 in myopathic patients, Fxr1-knockout mouse die
shortly after birth most likely due to an abnormal development of
cardiac and respiratory muscles [13]. A mouse model with
reduced levels of Fxr1 expression has also been generated, and
displays reduced limb musculature and a shorter life span of about
18 weeks [13]. Moreover, during Xenopus embryogenesis, complete
or partial inactivation of xFxr1 disrupts somitic myotomal cell
rotation and segmentation, impeding normal myogenesis [14].
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Finally, depletion of zFxr1p during early development of the
zebrafish leads to cardiomyopathy and muscular distrophy [15].
All these data point out an evolutionarily conserved role for
FXR1P in myogenesis.
FXR1P contains two KH domains and one RGG box that are
characteristic motifs in RNA-binding proteins [4,16]. In addition,
FXR1P harbours nuclear localization and export signals (NLS and
NES) enabling nucleocytoplasmic shuttling [4,17]. In most cell
types and tissues studied, FXR1P isoforms are associated to
messenger ribonucleoparticles (mRNPs) present on polyribosomes,
suggesting a consensus role in translation regulation for FXR1P
[18]. However, it was reported that, in undifferentiated myoblasts,
FXR1P long isoforms Isoe and Isof are not detected on
polyribosomes, suggesting a role other than translation regulation
for these isoforms at this stage [7,8]. Very few specific target
mRNAs for FXR1P have been identified so far, and even more
scarcely in the context of myogenesis. First, two independent
studies reported that the shortest isoform of FXR1P, Isoa, binds
the AU-rich element (ARE) present in the 39UTR of proin-
flammatory cytokine tumor necrosis factor (TNFa) mRNA [19,20].
In this context, FXR1P associates with AGO2 on TNFa2ARE to
modulate its translation [20]. Second, we have previously shown
the ability of FXR1P Isoe, its long muscle-specific isoform, to
interact specifically and with high affinity with the G-quadruplex
RNA structure in vitro [21]. However, no mRNA target of FXR1P
bearing a G-quadruplex has been identified yet in vivo. Finally, one
study reports the presence of Desmoplakin and Talin2 mRNAs in
FXR1P-mRNP complexes and subsequent disturbance of the
expression of the encoded proteins in Fxr1-KO heart extracts [22].
However, neither the binding motif/sequence recognized by
FXR1P on these mRNAs nor the exact functional significance of
these interactions have been explored.
To gain further insights into the muscular roles of FXR1P and
the pathways perturbed in its absence, we performed a large-scale
microarray analysis of the C2C12 myoblastic cell line inactivated
for Fxr1. This analysis revealed that Fxr1-depletion lead to
premature cell cycle exit of myoblasts. We link this to a robust
increase in the levels of the cyclin-dependant inhibitor p21/
Cdkn1a/Cip1/Waf1, that is also observed in FSHD-derived
myoblasts. In this study, we further explore the role played by the
direct interaction of FXR1P with p21 mRNA in the post-
transcriptional control of p21 levels.
Results
Inactivation of Fxr1 in C2C12 myoblasts selectively affects
the expression of a range of genes associated with cell-
cycle regulation during muscle development
To understand the functional role of FXR1P in myoblasts, we
used as a cellular model the C2C12 myoblastic cell line. This
murine cell line enables to reproduce myogenesis in vitro [23] and
expresses all the myogenic factors as well as FXR1P [7,8]. In this
model, we inactivated the expression of all FXR1P isoforms by
transient transfection of siRNAs targeting exon 14, a constitutive
exon present in all Fxr1 mRNAs [6]. As shown in Figure 1A,
quantitative RT-PCR performed on C2C12 cells transfected with
siFxr1 siRNAs reveals a significant reduction in Fxr1 mRNA as
compared to siControl-transfected cells (13.45%63.4% residual
expression, Figure 1A). Knockdown of all isoforms of FXR1P was
obtained by siFxr1 transfection, as shown by western-blot analysis
using the 3FX antibody (Figure 1B, [8]). Note that the levels of
FXR2P, the close homologue of FXR1P, also recognized by 3FX
antibody, remain unaffected, confirming the specificity of the
knockdown strategy (asterisk, Figure 1B). In siFxr1-transfected
myoblasts, the decrease in epifluorescence signal after FXR1P-
immunolabeling as compared to siControl-transfected cells con-
firms the efficiency of the knockdown (Figure 1C). The knockdown
appears to homogenously affect all the cells since the signal is
uniformly decreased. Note that in C2C12 cells, FXR1P immuno-
reactivity is mainly cytoplasmic, however, signal is also detected in
the nucleus (Figure 1C). Indeed, we confirmed the partial nuclear
localization of FXR1P in myoblasts by confocal microscopy
(Figure 1D), as described previously for the long isoforms of
FXR1P in C2C12 myoblasts [7] and in human myoblasts [9].
To determine the impact of the inactivation of Fxr1 on gene
expression in myoblasts, total RNA was extracted from siControl
and siFxr1-transfected C2C12 myoblasts and simultaneously
analysed using whole genome mouse microarrays. Among the
genes showing measurable differential levels of expression, a
significant change was observed for 105 transcripts (32 down- and
73 up-regulated) of which 79 were annotated in the RefSeq
database (Figure 1E and Table S1). As expected, Fxr1 mRNA
appears among the most significantly down-regulated in siFxr1-
transfected cells (Figure 1E and Table S1). To confirm the
observed dysregulation of a subset of mRNAs in Fxr1-knockdown
C2C12 myoblasts, we performed quantitative RT-PCR analysis
(Figure 1F). Interestingly, in Fxr1-depleted myoblasts, we were able
to confirm by quantitative RT-PCR a significant upregulation of
mRNAs encoding: Semaphorin 7a (Sema7a), the Ca2+-binding
multiple C2 domains transmembrane protein 2 (Mctp2), asialogly-
coprotein receptor 1 (Asgr1), the cyclin-dependant kinase inhibitor
p21 (p21/Cdkn1a/Waf1/Cip1), Hepatocyte growth factor (Hgf),
Dual specific phosphatase (Dusp6) and finally Limb-bud and heart
protein (Lbh, Figure 1E). Conversely, we confirmed a significant
down-regulation of Cdk15 mRNA encoding the cyclin-dependent
kinase 15. Finally, the mRNAs encoding the myoregulatory factors
MyoD and Myogenin for which no mRNA variations were
detected by microarray analysis remained unaffected (Figure 1F).
These analyses were further repeated on C2C12 cells inactivated
for Fxr1 by transfection of a different siRNA (siFxr1#2) targeting
Author Summary
Muscle development is a complex process controlled by
the timely expression of genes encoding crucial regulators
of the muscle cell precursors called myoblasts. We know
from previous studies that inactivation of the Fragile X
related 1 (FXR1) gene in various animal models (mouse,
frog, and zebrafish) causes muscular and cardiac abnor-
malities. Also, FXR1P is reduced in a human myopathy
called Fascio-Scapulo Humeral Dystrophy (FSHD), suggest-
ing its critical role in muscle that findings presented in this
study contribute to elucidating. Cell-cycle arrest is a
prerequisite to differentiation of myoblasts into mature
myotubes, which will form the muscle. One key regulator
is the p21/Cdkn1a/Cip1/Waf1 protein, which commands
myoblasts to stop proliferating, and this action is partic-
ularly important during muscle regeneration. In this study,
we have identified FXR1P as a novel regulator of p21
expression. We show that FXR1P absence in mouse
myoblasts and FSHD-derived myopathic myoblasts in-
creases abnormally the levels of p21, causing a premature
cell cycle exit of myoblasts. Our study predicts that FXR1P
absence leads to a reduced number of myoblasts available
for muscle formation and regeneration. This explains the
drastic effects of FXR1 inactivation on muscle and brings a
better understanding of the molecular/cellular bases of
FSHD.
Muscle-Specific FXR1P Isoforms Regulate p21 Levels
PLOS Genetics | www.plosgenetics.org 2 March 2013 | Volume 9 | Issue 3 | e1003367
Fxr1 exon 6, another constitutive exon of Fxr1 present in all its
variants [6]. This second siRNA leads to a 37% residual
expression of Fxr1 mRNA (Figure S1A) and reduces all FXR1P
isoforms (Figure S1B) as compared to siControl. In addition,
siFxr1#2-mediated knockdown of Fxr1 efficiently modulated the
previously studied subset of mRNAs to induce variations similar to
the one observed with the first siRNA against Fxr1 (Figure S1C).
Importantly, this cross-analysis using two siRNAs targeting distinct
regions of Fxr1 mRNA exclude the fact that the observed
variations could derive from off-target effects of the siRNAs.
To gain insights into the pathways perturbed by Fxr1 depletion,
we performed an analysis of the biological functions or processes
selectively enriched among the altered transcripts, using the
Ingenuity Pathway Analysis (IPA) software (Table S2). Interest-
ingly, Fxr1 knockdown in C2C12 myoblasts significantly affected
the functional categories ‘cell cycle’ (Table S2), ‘skeletal and
muscular system development and function’ and ‘skeletal and
muscular disorders’ (Table S2). Importantly enough, a subset of
mRNAs perturbed in siFxr1-knockdown myoblasts compared to
control repeatedly appeared determinant for the definition of the
affected functional categories: the cyclin-dependent kinase (Cdk15),
Figure 1. Microarray analysis of Fxr1-depleted C2C12 myoblasts. (A) Quantitative RT-PCR reveals a strong reduction of Fxr1 mRNA in C2C12
cells transfected with siRNA against Fxr1 compared to siControl-transfected cells. (B) Western-blot analysis of untransfected (UT) and siFxr1-
transfected cells (siFxr1) revealed with the antibody#3FX recognizing all isoforms of FXR1P reveals a strong depletion of all isoforms of FXR1P (short,
medium and long) compared to control (siCtl), while the levels of FXR2P protein (asterisk, *) remain unchanged. b-tubulin (b-tub) signal is used to
verify equal loading of lanes. (C) Immunofluorescence analysis of FXR1P (red) subcellular distribution in siControl and siFxr1-transfected cells, using
polyclonal #830 anti-FXR1P antibodies. Nuclei were counterstained with DAPI (blue) and merge images are shown in the right panel. The same
exposure time was used for both image captures and reveal a strong depletion in FXR1P signal in siFxr1-transfected cells compared to control
(siControl). Scale bar: 15 mm. (D) Confocal micrographs of C2C12 cells immunostained for FXR1P reveal a nucleocytoplasmic distribution of FXR1P.
Please note the nuclear dot-like structures containing FXR1P. Slice depth: 1 mm, scale bar: 15 mm. (E) Volcano plot showing the distribution of
differentially expressed transcripts between C2C12 cells transfected with siRNA against Fxr1 versus siControl-transfected cells. Log of the fold of
change (LogFC) is plotted against the B-statistic value for each transcript. A subset of 9 transcripts selected for further validation by Quantitative-RT
PCR (Fxr1, Cdk15, Sema7a,Mctp2, Asgr1, Hgf, p21, Dusp6 and Lbh) are highlighted. Significantly down- and up-regulated genes are shown in green and
red, respectively. (F) Quantitative-RT PCR analysis of a subset of mRNAs confirm that Sema7a, Mctp2, Asgr1, p21, Hgf, Dusp6, Lbh, MyoD and Myog are
significantly upregulated in Fxr1-depleted C2C12 myoblast, while Cdk15 is downregulated, confirming the microarray analysis. Data are presented as
means 6 SEM of n = 4 experiments.
doi:10.1371/journal.pgen.1003367.g001
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the cyclin-dependent kinase inhibitor (p21/Cdkn1a/Cip1/Waf1)
and the Hepatocyte growth factor (Hgf).
Fxr1-depletion in myoblasts leads to premature exit of
cell cycle
One of the most recurrent terms in IPA analysis of dysregulated
mRNA upon Fxr1 depletion were ‘cell cycle progression’, ‘arrest in
G0/G1’, ‘proliferation’ and also ‘cell viability’ (Table S2). This
prompted us to analyse myoblasts’ viability and proliferation
abilities upon Fxr1-depletion. Fluorescence-Activated Cell Sorting
(FACS) analysis of the DNA intercalant Propidium Iodide (PI)
incorporation on living cells allowed us to detect no changes in the
overall viability of Fxr1-knockdown (92.5% viability) compared to
control (90.53% viability) C2C12 cells (Figure 2A). To assess the
proliferation ability of Fxr1-depleted myoblasts, we conducted
tetrazole MTT proliferation assays. Interestingly, after 48 hours in
culture, siFxr1-transfected C2C12 cells exhibit a significant 15%
decrease in MTT reductase activity as compared to control
(Figure 2B). This suggests that Fxr1 depletion may induce
alterations of myoblasts cell cycle. We therefore further analysed
the distribution in the various cell cycle phases of siFxr1- or
siControl transfected myoblasts. The DNA content of the cells was
assessed by FACS-measurement of the amount of PI incorporated
in cells. Surprisingly, in a normal asynchronous cell population, we
did not observe any significant change in the cell cycle phases
distribution of the C2C12 cells transfected with siFxr1 or
siControl, in normal growth conditions (Figure 2C).
To highlight specific defects in cell cycle, we synchronized
siFxr1- and siControl-transfected myoblasts by treatment with the
cell cycle blocker mimosine, that arrests cell cycle progression at
the G1/S phase border [24]. Since the effects of this cell cycle
blocker are fully reversible, we then allowed the synchronized cells
to reenter cell cycle by incubating them in normal growth medium
for 16 hrs before FACS analysis. In these conditions, we did
observe a significant 27.6% increase in the number of cells in the
G0/G1 phase in Fxr1-knockdown myoblasts, as compared to
control. This increase in the G0/G1 population is accompanied by
a 51.9% decrease in the number of cells in the G2/M phase.
Importantly, no differences were observed in the proportion of
cells in the Sub-G1 phase - corresponding to cellular debris with a
lower DNA content liberated by apoptotic cells [25]- in
asynchronous cells (Figure 2A) and after release from cell cycle
blocker (Figure 2D). These data indicate that FXR1P depletion in
myoblasts does not lead to cell viability defects but rather causes a
blockade and accumulation of cells in the G0/G1 phase to the
detriment of mitosis.
Thus, to determine whether the cells were blocked in G0 or G1,
we performed immunolabeling of C2C12 cells in normal growth
conditions and quantified the number of DAPI-positive nuclei and
the amount of cells positive for the proliferation marker Ki67
(Figure 3). We observed that the number of nuclei in cultures of
siFxr1-transfected myoblasts is decreased by 26%, suggesting that
Fxr1 depletion limits the proliferating abilities of myoblasts
(Figure 3B). Quantification of cells expressing Ki67 enabled us
to detect that siRNA-meditated depletion in Fxr1 leads to a subtle,
but significant 10% decrease in the number of Ki67-positive cells
compared to control (Figure 3C). Since Ki67 is expressed during
all active phases of the cell cycle (G1, S, G2, and mitosis), but
absent from quiescent cells (G0) [26], the unlabeled cells most
likely represent resting cells blocked in G0.
The absence of FXR1P in C2C12 cells and in FSHD
patients-derived myoblasts affects the levels of
endogenous p21 mRNA and protein
The premature cell cycle arrest we observed in Fxr1-depleted
myoblasts prompted us to examine the subset of deregulated
mRNAs identified by microarray analysis in order to identify
candidates for regulation by FXR1P that could contribute to
explain this phenotype. The most promising mRNA candidate
appeared to encode the ubiquitous cyclin-dependent kinase
inhibitor (CDKI) p21 –also known as Cdkn1a/Cip1/Waf1- that
belongs to the Cip/Kip family of CDKI. In myoblasts, p21 is
known to block cell cycle progression to trigger cell-cycle exit, a
prerequisite to muscular differentiation [27,28,29].
In Fxr1-depleted myoblasts, we found that p21 mRNA level is
significantly increased by microarray analysis (Figure 1E, Table
S1) and confirmed a 1.76-fold upregulation of the transcript by
quantitative-RT PCR in these Fxr1 loss-of-function experiments (cf
Figure 1F). This upregulation of p21 mRNA level in Fxr1-depleted
myobasts was further confirmed using a second siRNA targeting
Fxr1 (Figure S1). We had previously shown that the muscle-specific
long isoforms of FXR1P, notably Isoe, are depleted in myoblasts
derived from Fascio-ScapuloHumeral Distrophy (FSHD) patients
and had hypothesized that this could induce deregulation of
mRNA targets specific to this isoform FXR1P Isoe [9]. To test this
hypothesis on this new potential mRNA target of FXR1P, we
assessed the status of human P21 in the same samples used in our
previous study. Interestingly enough, P21 mRNA levels are
significantly increased in FSHD patients by a 1.8 factor
(Figure 4A).
We then sought to verify whether this increase in p21 at the
mRNA level was translated at the protein level by western-blotting
(WB) analysis. Quantification of WB of siFxr1-transfected C2C12
using the ImageJ software revealed a 1.92 fold increase in p21
protein levels (Figure 4B). Concomitantly, we observed by western-
blotting that the levels of P21 protein are increased in FSHD
myoblasts compared to control by a 1.66 factor (Figure 4C). These
data indicate that depletion of FXR1P and particularly of its long
muscle-specific isoforms increases p21 mRNA and correlatively
increase the levels of p21 protein both in murine and human
myoblasts.
To assess the specificity and the direct nature of the effects we
observed on p21 mRNA levels by FXR1P loss of function
experiments, we first used a gain-of-function approach. For these
experiments, we used FXR1P long isoform Isoe since its depletion
in FSHD myoblasts recapitulates the effects on p21 mRNA levels
of a knockdown of all FXR1P isoforms in C2C12 cells (cf Figure 4).
Interestingly, in contrast to Fxr1 loss-of-function in C2C12
myoblasts, over expression of FXR1P Isoe lead to a 19,1%
significant decrease in endogenous p21 mRNA levels as compared
to transfection with empty vector (Figure 5A). This ascertains the
fact that the effects we observe on p21 mRNA levels are directly
related to the levels of FXR1P present in the cell. Secondly, we
performed rescue experiments using a pTL1 plasmid bearing
FXR1 Isoe cDNA in which we generated by site-directed
mutagenesis 4 mismatches to avoid recognition of the transgene
by siFxr1 (Figure 5B). This strategy enabled to efficiently re-
express FXR1P Isoe in Fxr1-knocked down myoblasts (Figure 5C).
Rescue of the expression of FXR1P Isoe lead to a significant
reduction in p21 mRNA levels as compared to unrescued
myoblasts. The rescue with FXR1P Isoe is total since the levels
of p21 mRNA in rescued cells are restored to control levels. Of
notice, similar results were obtained using another mutant plasmid
of pTL1.Isoe (data not shown), confirming the efficiency of the
rescue strategy.
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These data confirm the specificity of our approach and suggests
that p21 mRNA may be a target of FXR1P in C2C12 murine
myoblasts and in human myoblasts, either directly by RNA-
protein physical interaction, or indirectly by modulating a
pathway involved in p21 levels controls.
p21 mRNA is a novel mRNA target of FXR1P, both in vitro
and in vivo
Murine p21 mRNA is 1910 nts long (GenBank Accession
number: GI 161760647), with a very short 59UTR of less than
100 nts, a 480 nts coding sequence and a 1329 nts long 39UTR
where lie most of the regulatory elements for the stability of this
mRNA (Figure 6A). Notably, the ARE located at position 86–
103 nts on the 39UTR is bound by the RNA-binding protein HuR
to regulate the stability of the mRNA during muscle differentiation
[30]. Given the ability of FXR1P Isoa to bind ARE sequences
[19,20], we hypothesized that the ARE present in p21 mRNA
could be the binding site of FXR1P.
To test the physical interaction between FXR1P and p21
mRNA and determine the portion of the mRNA involved in the
interaction, we performed in vitro filter-binding assays [21] using
recombinant FXR1P and radiolabeled fragments of p21 mRNA
39UTR described in Figure 5A. We chose to use FXR1P Isoe, the
longest muscle-specific isoform of FXR1P for binding experiments
since i) it was described to have RNA-binding properties [21], ii) its
depletion in FSHD myoblasts recapitulates the effect on p21
mRNA levels of a complete knockdown of all FXR1P isoforms in
C2C12 cells (cf Figure 4) and iii) Isoe is able to restore p21 mRNA
levels to normal in Fxr1-knockdown myoblasts (cf Figure 5). As
controls for interaction, we used the N19 fragment of FMR1
mRNA containing a G-quadruplex RNA structure [31], known to
be specifically bound by FXR1P Isoe, and its truncated version
N19D35 unable to be bound by FXR1P [21]. As expected,
FXR1P was able to recognize the G-quadruplex containing N19
fragment (Figure 6B). Surprisingly, the binding activity of FXR1P
towards p21 39UTR-a fragment (nts 1–345) that contains a well
Figure 2. Fxr1-depletion does not impair myoblasts viability but specifically induces accumulation in G0/G1 phase to the detriment
of mitosis. (A) PI incorporation in living siFxr1- or siControl-transfected cultures and subsequent FACS analysis was performed to show that viability
of the culture is not affected by Fxr1-depletion. (B) MTT colorimetric assay show that the proliferation abilities of C2C12 cells are significantly impaired
by Fxr1-depletion. (C) FACS analysis of the Propidium Iodure-stained DNA content of C2C12 cells transfected with siControl or siFxr1. Cells were
analysed in asynchronous conditions or following synchronisation treatment for 8 hrs with the cell cycle blocker mimosine (late G1) followed by
16 hrs release in normal growth medium (D). In asynchronous conditions, cell cycle distribution is similar in siControl or siFxr1 transfected cells.
Synchronisation of cells allows detecting significant differences in the distribution of the cells in the various cell cycle absence of FXR1P: increase in
the G0/G1 proportion and decrease in the G2/M. Data are presented as means 6 SEM of n= 4 experiments, with FACS analysis of a minimal cell
population of 15,000 for each condition and each experiment. The asterisk (*) indicates p,0.05 of a Mann & Whitney test.
doi:10.1371/journal.pgen.1003367.g002
Figure 3. Knockdown of FXR1P induces premature cell cycle exit of myoblasts. (A) Immunofluorescence analysis of C2C12 cells transfected
with siControl or siFxr1. Nuclei are stained with DAPI (blue) and cells expressing the proliferation marker Ki67 are labelled with FITC antibody (green).
Scale bar: 75 mm. (B) Quantification of the number of DAPI-stained nuclei. (C) Quantification of the number of Ki67-positive cells over total number of
nuclei quantified in (B). Quantification was performed using a macro developed with the ImageJ software. Data presented are mean of n= 4
experiments with analysis of 10 optical fields for each condition and each experiment. The asterisk (*) indicates p,0.05 for the Student T-test.
doi:10.1371/journal.pgen.1003367.g003
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characterized ARE sequence was null, being equal to the binding
activity of the negative control N19D35. Also, p21 39UTR-b
fragment (nts 324–868) was not recognized by FXR1P. Interest-
ingly, the most distal portion of p21 39UTR, termed c fragment
(nts 851–1321), was specifically bound by FXR1P. These data
indicate that FXR1P Isoe does not recognize p21 mRNA via the
ARE motif present in the proximal portion of the 39UTR (a
fragment), but most likely via an uncharacterized motif or
sequence present in the distal portion of its 39UTR-c fragment.
Knowing that FXR1P interacted, at least in vitro, with p21
mRNA, we further sought to validate that this interaction occurs in
vivo. To test this hypothesis, we isolated immunocomplexes
containing FXR1P by performing UV-crosslinking and immuno-
precipitation assays (CLIP, [32]). Immunoprecipitation of FXR1P
mRNA complexes was carried out using the polyclonal antibody
#830 against exon 16 of FXR1P present in all isoforms except the
short ones [7,8] on C2C12 cell extracts (Figure 6C). Control CLIP
was performed using non-immune rabbit IgGs. As expected, using
the #3FX monoclonal antibody [7] against the constitutive exon
14 present in all isoforms of FXR1P, all the isoforms of FXR1P
were detected in both inputs (Figure 6C, lane 1 and 2). Medium
and long isoforms of FXR1P were selectively enriched in #830
immunoprecipitates (Figure 6C, Lane 4) and concomitantly
depleted in #830 post-immunoprecipitation supernatant
(Figure 6C, lane 6). The low amount of FXR1P small isoforms
detected in the #830 immunoprecipitates most likely corresponds
to the fraction of small isoforms interacting with FXR1P medium
and long isoforms, since FXR1P is known to homodimerize [4]. In
contrast, FXR1P is not recovered in immunoprecipitates obtained
with control rabbit IgGs (Figure 6C, lane 3) and still present in the
corresponding post-immunoprecipitation supernatant (Figure 6C,
lane 5), confirming the specificity of the CLIP assay performed
with #830 antibodies.
RT-PCR analysis of mRNAs extracted from both inputs and
immunoprecipitates was then carried out (Figure 6D). The mRNA
encoding p21, b-tubulin and the myogenic factors Myogenin and
MyoD are detected in the input fractions (Figure 6D, lanes 1 and
2). Interestingly, only p21 mRNA was found selectively enriched in
#830 immunoprecipitates (Figure 6D, lane 4) as compared to
control immunoprecipitates (Figure 6D, lane 3), while Myogenin,
MyoD and b-tubulin mRNAs were undetectable. This confirms the
specificity of the approach and suggests that, in the C2C12
myoblastic cell line, endogenous p21 mRNA is present in mRNA
complexes containing FXR1P.
The c fragment of p21 39UTR recognized by FXR1P has
intrinsic stabilization properties
To elucidate the functional significance of FXR1P interaction
with p21 39UTR-c fragment, we conducted luciferase assays on
C2C12 cells expressing FXR1P normally (siControl-transfected)
and inactivated for Fxr1 (siFxr1-transfected). The various portions
of p21 39UTR used for binding assays were cloned in the 39 of
Renilla luciferase cDNA in a reporter system (Figure 7A). The
influence of the 39 regulatory elements on Renilla mRNA and
protein levels was then assessed, in the presence and in the absence
of FXR1P, and compared to control vector without regulatory
elements in the 39UTR (Figure 7B, 7C). In the presence of FXR1P
or when FXR1P is knocked-down, no significant difference to
control is observed in the Renilla mRNA levels, when its cDNA is
fused either to the proximal a or central b fragments of p21
mRNA 39UTR. However, the distal cfragment bound by FXR1P
significantly increases Renilla mRNA levels in the presence of
FXR1P (1.33-fold, Figure 7B). Intriguingly, removal of FXR1P by
siRNA-mediated knockdown potentiated the mRNA stabilizing
effect of the p21 39UTR-c fragment (1.76-fold; Figure 7B)
compared to control. To assess whether variations of Renilla
mRNA correlated to protein variations, we performed classical
luminescence luciferase assays (Figure 7C). Interestingly, Fxr1-
depletion lead to a significant increase in Renilla luciferase activity
when its cDNA was either fused to the central b or distal c
fragment of p21 39UTR (Figure 7C). However, the amplitude of
variation was, again, higher when considering the c fragment in
siControl conditions (2.2-fold) or Fxr1 knockdown conditions (3.4-
fold), compared to control empty vector. These data support the
Figure 4. FXR1P depletion in C2C12 cells and in myoblasts
derived from FSHD myopathic patients biopsies contributes to
a consistent increase in p21 mRNA that translates into
enhanced p21 protein levels. (A) Quantitative RT-PCR reveals a
significant increase of P21 mRNA in FSHD myoblats relative to control
individuals. Data are presented as means 6 SEM of n= 3 individuals/
group. (B) Representative western-blot of p21 protein levels in siControl
(siC) or siFxr1 (siFx)-transfected C2C12 cells. Densitometric quantifica-
tion of western-blots reveal that depletion of FXR1P by siRNA
transfection (siFxr1) leads to a significant increase of p21 protein levels
relative to siControl-transfected cells. Data are presented as means 6
SEM of n = 4 experiments. (C) Representative western-blot of P21
protein levels in FSHD patients and control individuals. Densitometric
quantification of western-blots reveals that muscle biopsies of FSHD
patients display a significant increase of P21 protein relative to controls.
Data are presented as means 6 SEM of n = 3 individuals/group. The
asterisks * and ** indicate respectively p,0.05 and p,0.01 of the Mann
& Whitney test.
doi:10.1371/journal.pgen.1003367.g004
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hypothesis that FXR1P normally destabilizes p21 mRNA via
binding to a motif present in the distal c portion of its 39UTR.
To test in vivo the hypothesis of FXR1P involvement in the control
of endogenous p21mRNA stability, we treated siControl- or siFxr1-
transfected C2C12 cells with the transcription inhibitor actinomycin
D (ActD), and measured the decay rate of p21 mRNA by
quantitative RT-PCR. Interestingly, p21 mRNA appears to cycle
rapidly in control myoblasts. Linear regression on semi-log values of
p21 mRNA decay rate in siControl-transfected cells, provides an
estimated half-life of 2.5760.14 hrs (Figure 7D), with only 16%
mRNA remaining after 8 hrs. Conversely, upon Fxr1-depletion, p21
mRNA decay rate is strongly affected and its half-life is significantly
increased, reaching 5.9860.42 hrs (p-val,0.05). As a consequence,
even after 8 hrs of ActD treatment, 43% of p21 mRNA is still
present (Figure 7D). The slowing down of p21 mRNA decay rate
following Fxr1-knockdown was further confirmed using 5,6-
Dichlorobenzimidazole riboside (DRB), an adenosine analogue
inhibiting mRNA synthesis (Figure S2). These data suggest that
Fxr1-depletion increases endogenous p21 mRNA stability.
The c fragment of p21 39UTR contains a highly
evolutionarily conserved G-quadruplex motif regulating
its stability
The previous data support a negative role for FXR1P in the
control of p21 mRNA stability via binding to the 561 nts long p21
39UTR-c portion. The next step was to determine the RNA motif
responsible for FXR1P recognition. So far, two mRNA motifs
have been described to be recognized by FXR1P: the ARE motif
of TNFa mRNA [20] and the G-quadruplex present in FMR1
mRNA [21]. Our in vitro data clearly indicate that the ARE
present in the 39UTR of p21 mRNA does not mediate the binding
of FXR1P Isoe to p21 mRNA, we therefore looked for the
presence of putative G-quadruplex motifs in the c fragment of p21
39UTR. For this purpose, we used the QGRS webtool [33] that
indicated three putative G-quadruplexes spread along the
sequence of the c fragment (Figure S3), and notably a high-score
central G-quadruplex motif (nts 931–955). It is worth noticing that
this high-score putative G-quadruplex is located within a 51 nts G-
Figure 5. FXR1P overexpression in Fxr1-depleted C2C12 cells restores p21 mRNA levels to normal. (A) Western-blot analysis (upper
panel) of C2C12 cells transfected with empty pTL1 vector or pTL1.FXR1 Isoe (pTL1.Isoe) construct indicate a strong expression of FXR1P long isoform
Isoe in transfected myoblasts. Quantitative RT-PCR (lower panel) reveals a significant decrease of p21mRNA levels in C2C12 myoblasts overexpressing
FXR1 Isoe, as compared to control. Data are presented as means 6 SEM of n = 3 independent experiments. (B) Western-blot analysis (upper panel) of
C2C12 cells transfected with control siRNA (siC) or siFxr1 (siFx) and empty pTL1 vector or a mutated version of pTL1.FXR1 Isoe (pTL1.Isoe*) bearing 4
mismatches in siFxr1 recognition sequence indicate a reexpression of FXR1P long isoform Isoe in Fxr1-depleted transfected myoblasts. In the western
blot FXR2P is indicated by (*) Quantitative RT-PCR (lower panel) reveals a significant increase of p21mRNA levels in C2C12 myoblasts transfected with
siFxr1 (siFx) and the empty vector (pTL1), as compared to control. This increase is restored to normal levels when FXR1P Isoe expression is rescued by
transfection of pTL1.FXR1 Isoe. Data are presented as means 6 SEM of n = 3 independent experiments. The asterisks * indicate p,0.05 of the
Wilcoxon paired test, ns indicates non significance.
doi:10.1371/journal.pgen.1003367.g005
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rich region (position 918–955, 54% of G). To confirm the
predicted G-quadruplex, we used the property of G-quadruplex
forming regions to be detected by comparing reverse transcriptase
elongation on RNA templates in the presence of either K+, Li+ or
Na+ [31]. Indeed, stabilization of G-quadruplex structures by K+,
but not by Li+ or Na+, results in cation-dependent pauses
detectable on a sequence gel. The experiments were performed
on the full-length 39UTR and on the c fragment alone and
allowed us to identify two strong (position 939 and 940) and two
weak G-quadruplex pauses (position 955 and 969) in the 39UTR
of p21 mRNA (Figure 8A). Both the full-length and the c fragment
exhibited the same pauses, indicating that the c fragment retains
the ability to form the G-quadruplex structure in a comparable
manner to the full-length native 39UTR (Figure 8A). Alignment of
sequences corresponding to G-rich regions of p21 distal 39UTR in
mouse and human indicate high evolutionary conservation of this
portion of non-coding sequences (Figure 8B) and argues in favour
of its functional importance.
To explore the functional role of the G-quadruplex present in
the 39UTR of p21 mRNA, we constructed c fragments mutants
with partial (cD9) or full (cD38) deletion of the G-rich region
containing the G-quadruplex (Figure 8C) that were cloned
downstream of Renilla luciferase mRNA. Then, the levels of Renilla
mRNA of the resulting constructs were assessed for each mutant in
C2C12 cells. As previously shown in Figure 6B, the presence of the
c fragment did increase significantly the levels of Renilla mRNA,
but partial or full deletion of the G-quadruplex potentiated the
increase in the cognate mRNA levels (Figure 8D), mimicking the
effect of Fxr1 knockdown in C2C12 cells (cf Figure 7B). These data
argue in favour of a role of the G-quadruplex in mRNA
stabilization that is potentiated by deletion of the binding site of
FXR1P.
Discussion
Over the last decade, studies in Fxr1-knockout models have
inferred that FXR1P plays a critical role in myogenesis [13,14,15].
However, even though FXR1P muscle-specific isoforms have
unique RNA-binding properties [21], no specific mRNA targets
and function have been identified so far for FXR1P in muscle. In
this study, we have explored the functional consequences of the
depletion of the FXR1P in myoblasts, with the purpose to
understand its role in the early stage of myogenesis and in the
cellular pathophysiology of FSHD, a human myopathy.
Figure 6. FXR1P selectively binds in vitro to the distal portion of p21mRNA 39 UTR and associates in vivo with p21mRNA. (A) Scheme
of the various portions of p21 mRNA 39 UTR (a, b and c) used for in vitro binding assays. Note that the a fragment contains a characterized ARE motif.
(B) Nitrocellulose filter binding assays to determine the portion of p21 mRNA bound by FXR1P. Radiolabeled mRNA probes were incubated with
increasing concentrations of recombinant FXR1P Isoe protein, the amount of radioactive probes recovered on filters after binding reaction is then
plotted against the concentration of proteins. The portion of FMR1 mRNA called N19 (known to be bound by FXR1P) and its truncated version
(N19D35) were used as controls. This reveals that the distal portion of p21 39UTR (c fragment) and N19 are selectively bound by FXR1P. Both the a
and b fragments from the 39UTR of p21 remain at background levels comparable to N19D35 binding to FXR1P. (C) Western-blot analysis of UV-
crosslinking and immunoprecipitation (CLIP) assay performed on C2C12 lysates using polyclonal antibodies raised against the C-terminus of FXR1P
(#830) and control rabbit IgG (R). Input lysates (lanes 1 & 2, Input, 1/50th), immunoprecipitates (lanes 3 & 4, IP, 1/5th) and post-immunoprecipitation
supernatants (lanes 5 & 6, post, 1/50th) were probed for FXR1P using the 3FX antibody. A selective enrichment in FXR1P medium and long isoforms is
observed in #830 immunoprecipitate (lane 3), concomitant with a depletion in these isoforms in the post-immunoprecipitation supernatant (lane 4)
as compared to corresponding controls (lane 3 & 5). (D) RT-PCR analysis of mRNAs associated with FXR1P complexes. RNA was extracted from input
and immunoprecipitate fractions described in (C), and used as template for RT-PCR. RT-PCR products obtained from inputs and immunoprecipitations
respectively from control with rabbit IgG (Lanes 1, 3) and immunoprecipitation of FXR1P using #830 (Lanes 2, 4) were separated and visualized by
agarose gel electrophoresis. This reveals that p21 mRNA is selectively enriched in the #830 immunoprecipitates, while the mRNAs encoding the
myogenic determination factors Myogenin and MyoD or the unrelated mRNA encoding b-tubulin are not recovered in any immunoprecipitates. The
symbol # indicates aspecific PCR products corresponding to b-tub primers dimers. DNA molecular weight markers presented on the gels are
respectively 100, 200, 300, 400, 500, 600, 800 and 1000 bp.
doi:10.1371/journal.pgen.1003367.g006
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Cellular pathways affected by Fxr1-depletion
Microarray analysis of our myoblastic model inactivated for
Fxr1 enabled to show that FXR1P depletion affects the expression
of a wide range of mRNA species that control several cellular
pathways. One of the most represented functional categories
correspond to ‘skeletal and muscular system development’ and
‘skeletal and muscular disorders’, in line with the evoked role of
FXR1P in myogenesis and its altered pattern of expression in two
human myopathies: FSHD [9] and DM1 [12]. Interestingly, the
functional category ‘cell cycle’ appears also overrepresented in the
affected functions, in particular, terms corresponding to ‘arrested
in G0/G1 phase transition’ (related to the genes p21/Cdkn1a,
HGF, IGF, IL6) actually reflect what we observed at the
physiological level for Fxr1 inactivated myoblasts which remain
blocked in the G0 phase, without undergoing further differenti-
ation. Apart from p21, several mRNAs with altered levels in the
absence of FXR1P seem to influence the functional categories
affected and appear iteratively in our Ingenuity pathway analysis.
These candidates for interaction with FXR1P in the context of
myogenesis now deserve further investigation. Notably, Hepatocyte
growth factor (Hgf) mRNA is significantly upregulated in the absence
of FXR1P (Table S1, Figure 1E and 1F, Figure S1) and is known
to play an essential role in the migration and proliferation of
myogenic cells [34]. Similarly, the Insulin-like growth factor 1 (Igf1)
would be a relevant target of FXR1P in the muscle context, since
Igf1 plays a key regulatory role in skeletal muscle development, as
well as muscle fiber regeneration and hypertrophy [35]. Finally,
Cyclin-dependent kinase 15 (Cdk15) mRNA which, contrary to p21
mRNA, is downregulated in Fxr1-deficient myoblasts (Table S1,
Figure 1E and 1F, Figure S1) would be an interesting candidate for
regulation of cell-cycle progression by FXR1P. In this case,
FXR1P would stabilize Cdk15 mRNA via recognition of a yet
unknown specific motif. Murine and human Cdk15 mRNA are not
annotated in the AREsite database [36] and therefore do not seem
to bear a canonical AU-rich element sequence in their 39UTR.
However, analysis of the 3672 nts long human Cdk15 mRNA
Figure 7. The c portion of p21 mRNA 39UTR modulates the
stability of the mRNA that is potentiated by FXR1P depletion.
(A) Scheme of the constructs bearing various portions of p21 mRNA
39UTR (a, b and c) used for luciferase assays. (B) Effect of p21 39UTR2a,
2b and 2c fragments on Renilla luciferase (Ren) mRNA levels in C2C12
cells transfected with control siRNAs (siControl) or siRNAs targeting Fxr1
(siFxr1). Quantitative RT-PCR analysis of the levels of Ren mRNA
normalised to Firefly (Luc) mRNA relative to the empty construct are
presented. In siControl cells, only the c fragment significantly increased
Ren mRNA levels, this effect is potentiated by Fxr1 depletion with siFxr1.
In contrast, the a and b fragment have no effect on Ren mRNA levels, in
the presence or absence of FXR1P. The results are presented as the
means6SEM of 4 experiments. (C) Effect of p21 39UTR and its a, b and c
fragments on Renilla Luciferase activity in C2C12 cells transfected with
control siRNAs (siControl) or siRNAs targeting Fxr1 (siFxr1). Results
presented here represent the mean of the ratio of Luc-FL, Luc-a, Luc-b
and Luc-c to Luc-empty signal. In siControl cells, only the c fragment
significantly increased luciferase activity. In siFxr1 transfected cells
compared to controls, the b and c fragments increased luciferase
activity, while the a fragment has no effect. However, the amplitude of
variation is greater with the c fragment and this effect is potentiated by
Fxr1 depletion. Six independent experiments in triplicate for each
transfection were quantified. For each transfection, Renilla was
normalized to Firefly luciferase activity. RLU, relative luciferase units.
(D) Fxr1-depletion increases the stability of endogenous p21 mRNA.
C2C12 transfected with siControl (empty squares) or siFxr1 (black
squares) were treated with the transcription inhibitor actinomycin D for
8 hrs. p21 mRNA levels were determined by quantitative RT-PCR at
several time points and normalised to levels before treatment (t0).
Percentage of remaining mRNA is plotted using a semi-log scale. Data
presented represent the mean of n = 3 experiments. The asterisks *
indicate p,0.05 of the Mann & Whitney test, while # and ## indicate
respectively p,0.05 and p,0.01 of the Wilcoxon test.
doi:10.1371/journal.pgen.1003367.g007
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using QGRS G-quadruplex mapping webtool reveals the presence
of 8 putative G-quadruplex sequences (Table S3), with 2 putative
G-quadruplex in the 39UTR that represent binding sites for
FXR1P. To ascertain the importance of FXR1P in the regulation
of its putative mRNA targets newly identified in this study, it
would be worth investigating the presence of ARE sequences, G-
quadruplexes RNA structures in their 39 untranslated region.
Role of FXR1P/G-quadruplex mRNA complex in the
destabilization of p21 mRNA
Adequate regulation of the balance between proliferation and
cell cycle arrest of myoblasts is a crucial step during myogenesis.
The decision to progress through a new division cycle appears
primarily regulated before the G1 to S phase transition, with p21
upregulation playing an important role in this process by blocking
the formation of proliferation-inducing Cyclin A/Cdk2-E2F
complexes [37]. In this context, p21 gene undergoes extensive
regulation, both at the transcriptional and posttranscriptional
level. Our data do not support a transcriptional mechanism for the
maintenance of elevated p21mRNA levels in Fxr1-depleted muscle
cells. Indeed, in myoblasts, p21 is under the sole transcriptional
control of the myogenic transcription factor MyoD that activates
its promoter [38]. Our microarray and quantitative RT-PCR
analyses reveal that MyoD levels remain normal in Fxr1-deficient
myoblasts (Figure 1E). Finally, in luciferase assays, Ren mRNA
levels are increased when p21 mRNA G-quadruplex region is
fused to its 39UTR, even though this mRNA does not contain the
endogenous promoter of p21/Cdkn1a gene (Figure 7B, Figure 8D).
Figure 8. The c portion of p21 mRNA 39UTR contains an evolutionary conserved G-quadruplex structure with mRNA stabilization
properties. (A) Cation-dependent termination of reverse transcription in the 39-UTR full-length (FL) or c fragment of p21 mRNA. Strong and weak
pauses of reverse transcriptase (RT) are, respectively, indicated by large and thin arrows. Numbers correspond to positions of RT pauses, position +1
being the first nucleotide following the stop codon. (B) Localization and conservation of the G-quadruplex structure detected in (A) on the sequences
of p21 39UTR from Mus musculus (Mmu) and Homo sapiens (Hsa). (C) Scheme of the constructs used for luciferase assays bearing the conserved G-
quadruplex of c p21 mRNA (boxed) and two versions where the G-quadruplex has been deleted partially (D9) and fully (D38). (D) Effect of p21 39UTR
G-quadruplex and its deletions on Renilla luciferase (Ren) mRNA stability in C2C12 cells. Quantitative RT-PCR analysis of the levels of Ren mRNA
normalised to Firefly (Luc) mRNA relative to the levels of the empty construct. The c fragment bearing the G-quadruplex significantly increases Ren
mRNA levels relative to empty vector. Partial or full deletion of the G-quadruplex sequence strongly increases Ren mRNA levels, both relative to
empty vector and to the G-quadruplex bearing fragment. The results are presented as the mean of 4 experiments (6SEM). The asterisks * and #
indicate p,0.05 respectively of the Wilcoxon test or of the Mann & Whitney test.
doi:10.1371/journal.pgen.1003367.g008
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These evidences privilege an FXR1P-mediated posttranscriptional
mechanism of regulation of p21 mRNA levels involving the
binding of FXR1P.
In myoblasts, FXR1P long isoforms Isoe and Isof are most likely
not playing a role in translational regulation, since they are
detected in the nucleus and faintly in the cytoplasm but do not
associate to polyribosomes [7,8,17,39]. On the other hand, we
cannot exclude a mechanism involving translational inhibition via
binding of small or medium isoforms of FXR1P to p21 mRNA to
another motif, which may be located in the central part of p21
mRNA 39UTR (b fragment) that activates translation in the
absence of FXR1P (Figure 7A, 7B). This would be consistent with
the previously described role of FXR1P small isoform Isoa in
translational control [20]. However, our data strongly support the
fact that the FXR1P-dependant translational control of p21
mRNA is mainly regulated by FXR1P long isoforms, notably Isoe,
via binding to a 39UTR-located G-quadruplex motif (Figure 8).
To date, the G-quadruplex has been described to be a negative
[31,40] or positive [41] regulator of translation, and a zip-code for
dendritic transport and synaptic localization [42] depending on its
location on the mRNA (e.g. 59UTR or 39UTR) (for review see
[43]). We report here an evolutionary conserved G-quadruplex
motif as a novel RNA-binding motif present in a G-rich region of
the distal portion of p21 mRNA 39UTR. This motif, distinct from
the classical ARE present in the proximal portion of the 39UTR
[30], appears nevertheless to control the stability of p21 mRNA.
Indeed, when fused to the 39UTR of Renilla luciferase, the G-
quadruplex induces an increase in RenillamRNA levels, (Figure 7B,
Figure 8D) and this effect is potentiated by deletion of the G-
quadruplex (Figure 8D). Collectively, these data argue that the G-
quadruplex of p21 mRNA 39UTR participates in the control of
mRNA stability via a mechanism involving FXR1P. A few reports
describe the involvement of 39UTR-located G-rich stretches as
downstream sequence elements (DSE) promoting polyadenylation
and leading to increased stability of mRNA when located
downstream the polyadenylation site [44,45]. However, in the
context of p21 mRNA, the G-quadruplex (position 918–955 nts)
located upstream of p21 mRNA polyadenylation site (AAUAAA
sequence in position 1309–1314 nts) could act as an upstream
sequence elements (USE) promoting polyadenylation, as described
for a U-rich sequence in Prothrombin mRNA 39UTR [46]. An
alternate mechanism would involve that FXR1P long isoforms
drive degradation of p21 mRNA via recruitment of microRNAs
and the RISC complex. RNA interference is well described to
occur in the cytoplasm, but it was recently shown that small non-
coding RNAs can associate with complementary pre-mRNA
target both in the nucleus and in the cytoplasm, by binding to
Ago2 [47]. The lattest is a key component of the RNA-Induced
Silencing Complex (RISC) [47] and a well-known interactor of
FXR1P in human cells [20], Xenopus oocytes [48], and in Drosophila
[49,50]. Interestingly, p21 mRNA 39UTR contains an evolution-
arily conserved binding site for miR-22 100 nts upstream of the G-
quadruplex motif (Figure S3). This microRNA was recently shown
to regulate p21 mRNA levels [47] and is bound in vivo by Ago2
[51]. In this context, Fxr1-depletion or p21 39UTR G-quadruplex
deletion could prevent recruitment of the RISC complex on p21
mRNA and contribute to increase its stability, ultimately leading
to an accumulation of p21 mRNA and of the cognate protein.
In myoblasts, FXR1P is not the sole RNA-binding protein
playing a key role in the regulation of p21 mRNA. Several reports
demonstrate the importance of the proximal ARE of p21 mRNA
39UTR- present in the a fragment- to control the stability of this
mRNA. In myoblasts, the ARE-mediated stabilization of p21
mRNA is mediated by cooperative binding of HuR and hnRNPC1
[30,52], while its decay is controled by KSRP [53]. Members of the
hnRNPE family of proteins, PCBP1 and 2, control the central part
of p21 39UTR -the b fragment- [54]. Finally, another hnRNPE,
PCBP4, binds and stabilizes the c fragment [55], while we show in
this study that binding of FXR1P to the G-quadruplex motif of p21
39UTR-c fragment destabilizes the mRNA. Here, we wish to
propose a double system of regulation in which FXR1P and PCBP4
cooperate to regulate the levels of p21 using the distal 39UTR while
HuR, RNPC1 and KSRP use the ARE in the proximal part. These
complex regulatory systems enable a fine-tuning of p21 mRNA
levels, and our data indicate a prominent role for FXR1P as a
modulator of p21 levels.
FXR1P control of p21 mRNA stability regulates myoblast
cell-cycle exit
We report that, when FXR1P is depleted in the C2C12 cell line
and in FSHD myoblasts, p21 levels increase (Figure 1, Figure 4).
As a consequence, a subset of myoblasts becomes more permissive
to cell cycle arrest, resulting in a reduced yield of myoblasts at each
cycle of division (Figure 2, Figure 3). We also observed that the
Cyclin-dependent kinase 15 (Cdk15) mRNA levels are decreased (Table
S1; Figure 1E and 1F; Figure S1) it would be worth investigating
whether its decreased levels also have an impact in this premature
cell-cycle exit we observe in Fxr1-depleted myoblasts. Our data are
in line with other studies in which overexpression of p21 in
myoblasts is sufficient to trigger cell cycle exit, even in mitogenic
medium [28,56,57]. In our study, p21 upregulation upon Fxr1-
depletion causes cell cycle exit without onset of differentiation.
Indeed, the levels of the myogenic factors MyoD and Myogenin
remain normal, as assessed by microarray (Table S1) and
quantitative RT-PCR (Figure 1F). Moreover, we did not observe
spontaneous myoblasts fusion into myotubes in Fxr1-knockdown
cultures in normal growth conditions, which would be indicative of
premature differentiation (Davidovic & Bardoni, unpublished
data). Nevertheless, it would be worth investigating in details the
impact of Fxr1-knockdown on the differentiation of C2C12
myoblasts. Indeed, our data predict that premature cell cycle exit
of myoblasts in the absence of FXR1P decreases the pool of
myoblasts available for differentiation. This would directly
contribute to explain the reduced musculature detected in Fxr1-
KO mice [13] and in xfxr1-knockdown Xenopus [14] at early stages
of embryogenesis and development.
The fact that p21 mRNA is an mRNA target for FXR1P Isoe
has also crucial implications for the understanding of the
pathophysiology of myopathies. Indeed, splicing defects of the
FXR1 gene in FSHD myoblasts leads to reduced expression of the
long FXR1P Isoe, the one that specifically binds p21 39UTR. We
and others have shown that FSHD myoblasts exhibited higher
levels of p21 than controls, under normal growth conditions (this
study and [58,59]). It is now tempting to speculate that depletion
in FXR1P Isoe directly participates to the physiopathology of
FSHD, by causing p21-mediated premature arrest of the cell cycle
in FSHD myoblasts. Ultimately, this may limit the pool of
myoblasts available for regeneration of muscle fibers, inducing
progressive muscle wasting in FSHD patients. This hypothesis is
supported by a study which demonstrates that p21 is essential for
normal myogenic progenitor cell function in regenerating skeletal
muscle [60]. A similar scenario may be envisioned in the case of
the mouse model of DM1 in which reduced expression of FXR1P
Isoe was determined [12].
Conclusions
In conclusion, our study highlights for the first time the direct
involvement of an RNA-binding protein, FXR1P, in a new
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pathway that regulates p21 levels to control myoblasts cell cycle
exit. Perturbations of this pathway will have a strong impact in
muscle development and implicates a new signal dependant on a
39-UTR located G-quadruplex-RNA structure. In the future it will
be important to explore the implication of FXR1P in pathophys-
iology of muscle disorders and the pleiotropic functions of FXR1P
during myogenesis. Furthermore, our study opens new perspec-
tives on the role of the other Fragile X related proteins in the
control of cell cycle. Noteworthy, FMRP is known to recognize G-
quadruplex mRNA structures and it would be tempting to
speculate that FMRP could control p21-dependant cell cycle exit
of neuronal progenitors during neurogenesis.
Materials and Methods
Cells
The C2C12 cell line, a subclone of the C2C4 murine myoblastic
cell line [61,62], was cultivated under confluence state in the
conditions described by ATCC. C2C12 cells were transfected with
siRNA targeting exon 14 or exon 6 of Fxr1 mRNA (see Table S1)
and/or constructs using the Lipofectamine 2000 reagent (Invitro-
gen), according to the manufacturer’s protocole. Control exper-
iments were performed using commercially available control
random siRNA of matching GC content (Invitrogen). Transfected
cells were always analysed 48 hrs post transfection. mRNA decay
experiments were performed by adding actinomycin D (Act D,
5 mg/mL) or 5,6-Dichlorobenzimidazole riboside (DRB, 50 mM)
to culture medium for 0 to 8 hrs.
Human myoblasts derived from muscle biopsies of n= 3 FSHD
patients and n= 3 controls of matching age and gender were
described in [9]. The procedures to generate myoblasts derived
from human muscle biopsies were agreed by the French Health
Authorities (AFSSAPS). Myoblasts cultures were established as
previously described [9].
Gene expression profiling
Total RNA of C2C12 cells transfected with siFxr1 or siControl
siRNAs was extracted using the RNeasy kit (Qiagen, Hilden,
Germany). Integrity of RNA was assessed by using an Agilent
BioAnalyser 2100 (Agilent Technologies) (RIN above 8). RNA
samples were then labeled with Cy3 dye using the low RNA input
QuickAmp kit (Agilent) as recommended by the supplier. 825 ng
of labeled cRNA probe were hybridized on 8660K high density
SurePrint G3 gene expression mouse Agilent microarrays. Two
biological replicates were performed for each experimental
condition. The experimental data are deposited in the NCBI
Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.
gov/geo/) under the series record number GSE40577. Normal-
ization of microarray data was performed using the Limma
package available from Bioconductor (http://www.bioconductor.
org). Inter slide normalization was performed using the quantile
methods. Means of ratios from all comparisons were calculated
and B test analysis was performed. Differentially expressed genes
were selected based on a B-value above 0. Data from expression
microarrays were analyzed for enrichment in biological themes
(Gene Ontology molecular function and canonical pathways) and
build biological networks using Ingenuity Pathway Analysis
software (http://www.ingenuity.com/) and Mediante (http://
www.microarray.fr:8080/merge/index), an information system
providing information about probes and data sets.
Quantitative RT–PCR
Total RNA was extracted from myoblasts using the RNeasy kit
(Qiagen, Hilden, Germany) and a reverse transcription (RT)
reaction was performed using the Superscript II RT-PCR system
(Invitrogen, Carlsbad, California, USA) according to the manu-
facturers’ protocol. RT products were subjected to polymerase
chain reaction (PCR). All primers were designed using the Primer
3 software (Table S4). Standard RT-PCR was performed using the
Promega PCR Master Kit (Promega, Madison, Wisconsin, USA).
Real-time PCR reactions were carried out using the Syber Green I
qPCR core Kit (Eurogentec, Lie`ge, Belgium) in a LightCycler
system (Roche, USA). The comparative threshold cycle (Ct) for the
amplicons of each sample was determined by the LightCycler
software and normalised to the corresponding Ct of TATA Box
Binding Protein (TBP) mRNA for endogenous p21 mRNA levels,
and to the Ct of Firefly luciferase in the case of Renilla luciferase
mRNA assessment. Finally, the 2-DDCt method [63] was used to
analyse the relative changes in the various studied mRNAs
between C2C12 myoblasts transfected with control siRNA
(Invitrogen) or anti-Fxr1 siRNA (Invitrogen), or between FSHD
myoblasts and controls (n = 3). Data were expressed as means
6SEM. Each assay was performed in triplicate with n= 3–4
independent replicates.
Immunoblot and immunofluorescence
Cell extracts were analysed by western blotting as described
previously [64,65]. Previously described primary antibodies
against FXR1P were polyclonal rabbit antibody #830 (1:5,000)
and monoclonal 3FX (1:500), the latter also cross-reacting with
FXR2P [7]. Anti-b-actin monoclonal antibody (Sigma) and anti-
p21 polyclonal rabbit antibodies (Santa Cruz) were used respec-
tively at 1:10,000 and 1:200. Digital acquisition of chemilumines-
cent signal was performed using the Las-3000 Imager system
(Fujifilm). Quantitation of western-blot was performed using the
ImageJ software and normalized to the b-actin signal.
Immunofluorescence was performed as described [9], using
anti-FXR1P #830 polyclonal antibodies (1:5,000; [8]) and anti-
Ki67 monoclonal antibody (1:100; Millipore). Secondary Alexa
594-coupled antibodies (Invitrogen, Carlsbad, California, USA)
were used at 1:250. After counterstaining with DAPI, coverslips
were mounted on slides with anti-fading reagent and observed
using a Zeiss Axioplan2 epifluorescence microscope equipped with
a CoolSNAP HQ CCD cooled camera (Roper Scientific) or an
Olympus FV10i confocal digital microscope. Micrographs were
then analysed with ImageJ software.
Cell viability and FACS analysis
For viability assessment 48 hrs post transfection with anti-Fxr1
and control siRNAs, both attached cells and culture supernatant
were collected and then incubated in the presence of propidium
iodide (PI, 50 mg/mL). The incorporation of PI in dead cells was
then analysed with a FACScan instrument (Becton, Dickinson).
MTT proliferation assay was used to determine the proliferation
ability of the cells as recommended by the manufacturer (Sigma).
For cell cycle distribution assessment, cells were fixed in 70%
ethanol, treated with RNAseA (50 mg/mL), stained with PI
(50 mg/mL) and their DNA content was assessed using FACS
analysis. For synchronisation experiments, cells were treated with
500 nM of the cell blocker mimosine for 8 hrs. Release from cell
cycle blockade was performed for 16 hrs in growth medium before
FACS analysis.
RNA–binding assays
Human FXR1P Isoe recombinant protein His-tagged in the C–
terminus was produced in bacteria using the pET21a/FXR1 Isoe
construct [21], as described [64]. The control RNA fragments
used in this study: N19 (RNA sequence derived from FMR1
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mRNA and containing a G-quadruplex forming structure) and
N19D35 (N19 sequence in which the G-quadruplex is deleted)
were cloned in pTL1 plasmid [31]. The various fragments from
p21 cDNA were amplified by RT-PCR of C2C12 cDNAs and
cloned in the pGemTEasy system (Promega) using the primers
described in Table S1, as advised by the manufacturer. For filter
binding assay, N19 or p21 constructs were in vitro transcribed using
T7 RNA polymerase (Promega), the RNA products being labeled
by cotranscriptional incorporation of [c232 P]-ATP. Labeled
RNAs were purified on a 1% low-melting agarose gel (Ambion).
Labeled RNAs (50,000 c.p.m., 4 fmol) were renatured for 10 min
at 40uC in binding buffer (50 mM Tris–HCl (pH 7.4), 1 mM
MgCl2, 1 mM EDTA, 150 mM KCl, 1 mM DTT). In the
presence of 2 U/mL of RNase inhibitors (RNasin, Invitrogen),
0,1 mg/mL of Escherichia coli total tRNA and 0.01% BSA,
radiolabeled RNA were incubated to increasing amounts of
FXR1P protein. RNA–protein complexes were allowed to form
for 10 min on ice, filtered through MF-membranes (0.45 HA,
Millipore) and washed with 2 mL binding buffer. Filters were air-
dried and Cerenkov counting was used to assess the levels of
remaining radioactivity on filters. Data were plotted as percentage
of total RNA bound versus the protein concentration and one-site
binding curve was drawn using the Prism 4 software.
UV-crosslinking and immunoprecipitation (CLIP)
To isolate mRNAs associated with FXR1P in vivo, UV-cross-
linking and immunoprecipitations (CLIP) were performed with
extracts of C2C12 cells using a protocol adapted from [65] and the
#830 polyclonal antibody directed against the C-terminus of
FXR1P [8]. For each assay, 10 mg of polyclonal antiserum was used
to immunoprecipitate 256106 cells. An equivalent amount of
unrelated rabbit IgGs (Sigma) were used as negative control.
Approximately 1/20th of the homogenate and 1/4th of the
immunoprecipitate were loaded on a 11% SDS–PAGE gel. Proteins
transferred onto a 0.45 mm nitro-cellulose membrane were revealed
using the 3FX antibody recognizing both FXR1P and FXR2P [8].
mRNAs were extracted from C2C12 input lysate and immunopre-
cipitates using Trizol reagent (Invitrogen) according to the
manufacturer’s protocole and subjected to reverse transcription
(RT) using the SuperscriptScript III RT-PCR system (Invitrogen).
RT products were subjected to polymerase chain reaction (PCR),
using a PCR Master Kit (Promega) and primers detailed in Table
S4 specific for p21, Myogenin, MyoD and b-Tubulin mouse cDNAs.
The PCR program consisted in 10 min. of initial denaturation at
95uC followed by 35 cycles 230 s. at 95uC, 30 s. at 58uC, 30 s. at
72uC- and a final elongation step of 10 min at 72uC. PCR products
were visualised on a 2% TAE agarose gel and amplicon size was
verified using the 1 Kb+ DNA ladder (Invitrogen).
Luciferase assays
Luciferase assays were performed using the pSiCheck2 system
(Promega) according to the manufacturer’s protocole. Briefly, the
various fragments from p21-39UTR cDNA (a, b and c) were
excised from the pGemTEasy vectors using the NotI site and
inserted downstream of the Renilla luciferase cDNA using the NotI
site of the pSiCheck2 vector. C2C12 cells were co-transfected in
96-well plates with the siRNA control or against Fxr1 and
pSiCheck2 constructs. Luciferase assays were performed 48 hrs
post transfection using the DualGlow Luciferase Kit (Promega)
according to the manufacturer’s protocole.
Constructs
pTL1/FXR1Isoe plasmid was cloned as described in [8]. The
mutated version of this plasmid bearing 4 silent mutations in
human FXR1 cDNA that impede recognition by siFxr1#1 was
produced by site-directed mutagenesis using primers described in
Table S4 and the QuickChange kit (Stratagene).
Statistical analysis
To compare numerical data, non-parametric Mann & Whitney
test was used for small sample size (n,30) and a Student T-test
was used when n.30. Wilcoxon non-parametric tests were used to
assess significance of Renilla luciferase mRNA or activity levels
variations between each fragment relative to the empty vector
(arbitrarily set to 1). All statistical analysis and data graphs were
performed with the Prism 4 software. Only significant differences
are displayed on the graphs.
Supporting Information
Figure S1 Confirmation of microarray mRNA candidates using
a second siRNA targeting another constitutive exon of Fxr1
mRNA (exon 6). (A) Quantitative RT-PCR reveals a strong
reduction of Fxr1 mRNA in C2C12 cells transfected with siRNA
against Fxr1 (siFxr1#2) compared to siControl-transfected cells.
(B) Western-blot analysis of untransfected (UT) and siFxr1-
transfected cells (siFxr1#2) revealed with the antibody #3FX
recognizing all isoforms of FXR1P reveals a strong depletion of all
isoforms of FXR1P (short, medium and long) compared to control
(siCtl), while the levels of FXR2P protein (asterisk, *) remain
unchanged. b-tubulin (b-tub) signal is used to verify equal loading
of lanes. (C) Quantitative-RT PCR analysis of a subset of mRNAs
confirm that Sema7a, Mctp2, Asrg1, Cdkn1a/p21, Hgf, Dusp6 and Lbh
mRNAs are significantly upregulated while Cdk15 mRNA is
downregulated in Fxr1-depleted C2C12 myoblasts, confirming the
microarray analysis and quantitative-RT PCR analysis using the
first siFxr1 siRNA. Data are presented as means 6 SEM of n= 4
experiments.
(TIF)
Figure S2 Confirmation that Fxr1-depletion increases the
stability of endogenous p21 mRNA using a second transcription
inhibitor. C2C12 transfected with siControl (empty squares) or
siFxr1 (black squares) were treated with the transcription inhibitor
5,6-Dichlorobenzimidazole riboside (DRB) for 8 hrs. Percentages
of remaining p21 mRNA at the various time points were
determined by quantitative RT-PCR and normalised to levels
before treatment (t0). During the first 5 hrs of treatment, p21
mRNA stability is clearly increased when FXR1P is knocked-down
by siFxr1 transfection, as compared to siControl-transfected cells.
At the dose used, DRB effect is reversible and transcription
resumes after 5 hrs of treatment resulting in a progressive increase
in p21 mRNA levels in both conditions.
(TIF)
Figure S3 Sequence analysis of p21 39UTR c fragment bound
by FXR1P in search for G-quadruplexes and microRNA binding
sites. The position and scores of the three putative G-quadruplexes
structures predicted by the webtool QGRS [33] in the c portion of
murine p21 mRNA 39UTR are boxed. The putative G-
quadruplex located between nts 931–955 displays a high score
of 38 and lies within a G-rich region (nts 918–968) in which G are
highlighted by empty circles (u). A conserved binding site for miR-
22/22-3p conserved among species is located in position 837–
843 nts, as predicted by TargetScan webtool.
(TIF)
Table S1 List of the 79 RefSeq annotated transcripts signifi-
cantly modulated after Fxr1-depletion in myoblasts. NCBI RefSeq
IDs give access to transcripts annotations. Logarithm (base 2) of
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the average intensity (AveExp) and logarithm (base 2) of the ratio
siFxr1/siControl are represented. The subset of mRNAs further
validated in quantitative RT-PCR are highlighted in bold.
(XLSX)
Table S2 Ingenuity Pathway Analysis of microarray data to
highlight selectively affected pathways in Fxr1-depleted myoblasts.
All the affected pathways ordered by p-value are presented in (A),
while pathways specifically related to ‘skeletal muscle’ or ‘cell
cycle’ are respectively presented in (B) and (C).
(XLSX)
Table S3 Prediction of G-quadruplexes present in human Cdk15
mRNA using QGRS webtool. G-quadruplexes displaying the
highest scores are localized in the 59UTR or coding sequence of
the mRNA.
(XLSX)
Table S4 List of primers used in study.
(XLSX)
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